Search filters

List of works by Koji Shinkai

An open study of risperidone liquid in the acute phase of schizophrenia

scientific article published in June 2005

Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment

scientific article

Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review

scientific article published in July 2004

Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells

scientific article

Effects of repeated milnacipran administration on brain serotonergic and noradrenergic functions in healthy volunteers

scientific article published on 8 July 2006

Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cells

scientific article

Grapefruit juice-fluvoxamine interaction--is it risky or not?

scientific article (publication date: August 2003)

Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea

scientific article published in January 2003

Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia

scientific article published in March 2003

Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.

scientific article

Risperidone in the treatment of psychotic depression

scientific article published on 06 March 2006

Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran

scientific article published on 09 January 2007

Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels

scientific article published in June 2006

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients

scientific article

Paulina is supported by:

About Paulina

Help